BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $50,000 | -99.3% | 50,000 | -99.1% | 0.00% | -100.0% |
| Q2 2020 | $7,240,000 | +12828.6% | 5,510,000 | +10296.2% | 0.00% | – |
| Q1 2020 | $56,000 | +3.7% | 53,000 | +6.0% | 0.00% | – |
| Q4 2019 | $54,000 | +5.9% | 50,000 | 0.0% | 0.00% | – |
| Q3 2019 | $51,000 | -8.9% | 50,000 | 0.0% | 0.00% | – |
| Q2 2019 | $56,000 | -1.8% | 50,000 | 0.0% | 0.00% | – |
| Q1 2019 | $57,000 | +1.8% | 50,000 | 0.0% | 0.00% | – |
| Q4 2018 | $56,000 | +1020.0% | 50,000 | +1150.0% | 0.00% | – |
| Q4 2017 | $5,000 | -99.5% | 4,000 | -99.5% | 0.00% | – |
| Q3 2016 | $1,050,000 | +293.3% | 842,000 | +274.2% | 0.00% | – |
| Q1 2016 | $267,000 | -60.9% | 225,000 | -55.4% | 0.00% | – |
| Q4 2015 | $682,000 | +20.1% | 505,000 | +20.0% | 0.00% | – |
| Q3 2015 | $568,000 | -41.8% | 421,000 | -31.0% | 0.00% | – |
| Q2 2015 | $976,000 | -85.4% | 610,000 | -86.3% | 0.00% | -100.0% |
| Q1 2015 | $6,706,000 | +335200.0% | 4,456,000 | +222700.0% | 0.00% | – |
| Q4 2014 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2014 | $2,000 | -99.8% | 2,000 | -99.8% | 0.00% | – |
| Q2 2014 | $1,020,000 | -1.6% | 975,000 | +5.2% | 0.00% | – |
| Q1 2014 | $1,037,000 | – | 927,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|